The Effect of Photodynamic Therapy Mediated by Mesoporous Silica Nanoparticles Containing Chlorin e6 and Indocyanine Green on 3D Prostate Cancer Model

Cancer is a disease that all humanity has been fighting for many years. There are many cases where traditional treatment methods are still ineffective. In order to treat cancer disease permanently, the life cycle of cancer cells must be stopped or destroyed, as well as the destruction of the physiologically formed microenvironment or the blood vessels that feed them. In this study, prostate cancer microtissues were created to mimic the specified cancer structure. A novel method, Photodynamic therapy (PDT), has been applied on microtissues in the presence of mesoporous silica nanoparticles (MSN) bearing chlorin e6 and indocyanine green. The photosensitizers were loaded on MSNs. A dual laser system built with 655 and 808 nm diode lasers was used to excite the photosensitizers in MSNs simultaneously. According to the results, optimum prostate tumor microtissue form was created. While the nanoparticle and light applications did not cause any toxicity alone, statistically significant phototoxicity was achieved in the PDT groups. 200 μg/ml of nanoparticle concentration induced approximately 60% decrease in the cell viability of the PC3 microtissues. In conclusion, the destruction of cancer cells in microtissues and increased photodynamic action were achieved.

[1]  Didem Şen Karaman,et al.  Enhanced photodynamic action with chlorin e6 and indocyanine green incorporated mesoporous silica nanoparticles against prostate cancer cells , 2021, European Conference on Biomedical Optics.

[2]  N. Topaloglu,et al.  Induced Photo-Cytotoxicity on Prostate Cancer Cells with the Photodynamic Action of Toluidine Blue Ortho. , 2021, Photodiagnosis and photodynamic therapy.

[3]  Mei-xia Zhao,et al.  The Apoptosis Effect on Liver Cancer Cells of Gold Nanoparticles Modified with Lithocholic Acid , 2018, Nanoscale Research Letters.

[4]  Alexander Muir,et al.  Microenvironmental regulation of cancer cell metabolism: implications for experimental design and translational studies , 2018, Disease Models & Mechanisms.

[5]  Jinping Wang,et al.  Theranostic Nanoplatform: Triple-Modal Imaging-Guided Synergistic Cancer Therapy Based on Liposome-Conjugated Mesoporous Silica Nanoparticles. , 2018, ACS applied materials & interfaces.

[6]  O. Karaman,et al.  Determination of minimum serum concentration to develop scaffold free micro-tissue , 2017 .

[7]  Sabrina Oliveira,et al.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions , 2017, Cancers.

[8]  M. Chorilli,et al.  Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review , 2016, Molecules.

[9]  Susan M. Huse,et al.  MCF-7 Human Breast Cancer Cells Form Differentiated Microtissues in Scaffold-Free Hydrogels , 2015, PloS one.

[10]  K. Soo,et al.  Nanoparticles in photodynamic therapy. , 2015, Chemical reviews.

[11]  R. Manavalan,et al.  Nanotherapeutics to overcome conventional cancer chemotherapy limitations. , 2011, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[12]  F. Berr,et al.  Photophysics and photochemistry of photodynamic therapy: fundamental aspects , 2009, Lasers in Medical Science.

[13]  C. Gomer,et al.  Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment , 2006, Lasers in surgery and medicine.

[14]  Stanley B. Brown,et al.  The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.

[15]  Thomas J. Dougherty,et al.  Basic principles of photodynamic therapy , 2001 .

[16]  R H Brook,et al.  Quality-of-life outcomes in men treated for localized prostate cancer. , 1995, JAMA.

[17]  C. Frochot,et al.  Inorganic Nanoparticles for Photodynamic Therapy. , 2016, Topics in current chemistry.

[18]  S. Acherar,et al.  Light-Responsive Nanostructured Systems for Applications in Nanomedicine , 2016 .

[19]  N. Prabhakar,et al.  Design considerations for mesoporous silica nanoparticulate systems in facilitating biomedical applications , 2014 .